Excessive scarring in glaucoma surgery. Part 2: Anti-inflammatory therapy, antimetabolites, angiogenesis inhibitors
Open Access
- 13 September 2025
- journal article
- Published by Research Institute of Eye Diseases in National Journal glaucoma
- Vol. 24 (3) , 66-75
Abstract
The main complication of glaucoma surgery is excessive scarring of newly created aqueous humor outflow pathways. To prevent fibrotic tissue formation, medications with different mechanisms of action are used intraoperatively and during the early postoperative period.The primary group of anti-inflammatory drugs used in glaucoma surgery are topical steroids. A particularly high antiinflammatory efficacy has been demonstrated with a slowrelease dexamethasone implant placed under the scleral flap.Nonsteroidal anti-inflammatory drugs, in addition to their direct effect, can potentiate the hypotensive action of prostaglandin analogs and reduce the severity of their local side effects. The use of antimetabolites such as mitomycin C and 5-fluorouracil is justified by their antifibrotic activity, which inhibits DNA synthesis and, consequently, the proliferation of cells including myofibroblasts. However, they are associated with a high risk of hypotonic complications. Angiogenesis inhibitors suppress vascular endothelial growth factor production and thus block proliferation.The use of ranibizumab, bevacizumab, and infliximab as adjuncts to standard therapy can enhance the longterm effectiveness of glaucoma surgery. However, their use remains limited and not fully explored.Keywords
This publication has 33 references indexed in Scilit:
- Clinical observation of ranibizumab combined with surgery in the treatment of neovascular glaucoma with vitreous hemorrhageInternational Ophthalmology, 2022
- Assessing safety and success after using bevacizumab, 5-fluorouracil or placebo in primary trabeculectomy. A prospective randomized placebo controlled 1-year follow-up studyCutaneous and Ocular Toxicology, 2022
- Prostanoid receptor agonists for glaucoma treatmentJapanese Journal of Ophthalmology, 2021
- Ocular Surface Disease and Glaucoma Medications: A Clinical ApproachEye & Contact Lens: Science & Clinical Practice, 2019
- Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgeryCochrane Database of Systematic Reviews, 2015
- 5-Fluorouracil for glaucoma surgeryCochrane Database of Systematic Reviews, 2014
- Level of Vascular Endothelial Growth Factor in Tenon Tissue and Results of Glaucoma SurgeryArchives of Ophthalmology (1950), 2012
- Bleb Morphology and Vascularity After Trabeculectomy With Intravitreal Ranibizumab: A Pilot StudyAmerican Journal of Ophthalmology, 2010
- VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNAExperimental Cell Research, 2005
- Ocular Hypotensive FP Prostaglandin (PG) Analogs: PG Receptor Subtype Binding Affinities and Selectivities, and Agonist Potencies at FP and Other PG Receptors in Cultured CellsJournal of Ocular Pharmacology and Therapeutics, 2003